GSA Capital Partners LLP cut its stake in Monsanto (NYSE:MON) by 65.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,925 shares of the basic materials company’s stock after selling 3,685 shares during the quarter. GSA Capital Partners LLP’s holdings in Monsanto were worth $231,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in MON. Bruderman Asset Management LLC purchased a new position in Monsanto during the second quarter worth about $116,000. Tower Research Capital LLC TRC grew its position in Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares in the last quarter. Americafirst Capital Management LLC purchased a new position in Monsanto during the third quarter worth about $148,000. Fieldpoint Private Securities LLC grew its position in Monsanto by 100.6% during the second quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after buying an additional 790 shares in the last quarter. Finally, Loews Corp purchased a new position in Monsanto during the second quarter worth about $202,000. Institutional investors own 75.34% of the company’s stock.

In other news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the sale, the vice president now directly owns 38,600 shares of the company’s stock, valued at approximately $4,718,850. The disclosure for this sale can be found here. Insiders sold a total of 20,310 shares of company stock valued at $2,458,328 over the last quarter. Company insiders own 0.79% of the company’s stock.

Monsanto (NYSE MON) opened at $119.70 on Friday. Monsanto has a fifty-two week low of $106.74 and a fifty-two week high of $122.79. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. The stock has a market capitalization of $52,700.19, a PE ratio of 20.86, a PEG ratio of 1.71 and a beta of 1.04.

Monsanto (NYSE:MON) last posted its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.77 billion. During the same quarter in the previous year, the company posted $0.21 earnings per share. Monsanto’s revenue for the quarter was up .3% compared to the same quarter last year. research analysts anticipate that Monsanto will post 5.76 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s payout ratio is currently 39.85%.

MON has been the subject of several recent analyst reports. Wells Fargo & Co boosted their target price on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Barclays restated an “equal weight” rating and set a $124.00 target price (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Jefferies Group restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research report on Friday, September 15th. Finally, BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto in a research report on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $126.40.

ILLEGAL ACTIVITY NOTICE: “GSA Capital Partners LLP Sells 3,685 Shares of Monsanto (MON)” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/gsa-capital-partners-llp-sells-3685-shares-of-monsanto-mon/1805462.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with Analyst Ratings Network's FREE daily email newsletter.